BetterLife Pharma Inc.: BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

BetterLife Pharma (CSE: BETR) closed a US$100M offering, issuing 447M common shares at CDN$0.25 each and 108M pre-funded warrants. Proceeds will fund BETR-001 clinical trials for neurological disorders. Investors include Deep Track Capital and other healthcare-focused funds. The company granted agents a 7% commission and warrants.

BetterLife Pharma Inc. (CSE: BETR) filed a final prospectus for a US$100 million public offering of common shares and pre-funded warrants. The offering, led by Bloom Burton Securities and Haywood Securities, aims to raise up to US$100 million with a minimum of US$80 million. Proceeds will fund clinical trials for neurological disorder treatments and general corporate purposes. The offering is expected to close on or around September 17, 2026, subject to regulatory approvals.

General Motors (GM) has aggressively reduced its shares outstanding by 40% since 2023 through buybacks, boosting EPS and stock price. GM announced a $20B share repurchase program, which could further reduce shares and increase EPS. GM's total yield, including buybacks, is 12.59%, higher than Ford's 5.7%. GM's strong cash flow supports its buyback plans.

Getty Images filed for Chapter 11 bankruptcy protection, aiming to restructure and go private. The company cited heavy debt ($2.1B) and competition from AI image generators. Existing shareholders will lose equity, while Getty family and Koch Equity Development will provide $533M in financing. The process is expected to complete by year-end, with normal operations continuing.

Align Technology (ALGN) reports Q3 earnings on Oct 28. Q2 saw record aligner shipments (+7.4% YoY) but scanner revenue fell 10.8%. International growth offset North American softness. Analysts expect Q3 revenue of $1.004B (+0.9% YoY) and EPS of $2.77 (+6.0% YoY). Management anticipates ASP declines due to pricing pressure and geographic mix. Scanner revenue is guided down 6-8% for 2026. Shares are down 1.05% YTD.

Nebius (NBIS) secured a $3.5B senior secured loan from Citi, maturing in 364 days, for data center development and GPU procurement. Q2 revenue surged 454% to $582.3M, but meeting $7B-$9B annual target requires significant second-half growth. The company has $10B in convertible debt outstanding, with a key Q3 report due November 12.